allyl-{4-[3-(4-bromo-phenyl)-benzofuran-6-yloxy]-but-2-enyl}-methyl-amine

Allyl-{4-[3-(4-Bromo‑Phenyl)‑Benzofuran‑6‑Yloxy]‑but‑2‑Enyl}‑Methyl-Amine is a synthetic small molecule belonging to the phenylbenzofurans class of organic compounds. It has been catalogued in chemical and pharmaceutical databases (e.g., DrugBank, ChEMBL, PubChem), but there is no evidence of clinical use or approval for any medical indication. The compound is considered experimental and has not advanced beyond preclinical or early research stages. Its mechanism of action, biological targets, pharmacological activity, and therapeutic potential have not been established in the literature or public drug development pipelines[1][2][6].

Other names

Allyl-(4-(3-(4-Bromo-Phenyl)-Benzofuran-6-Yloxy)-but-2-Enyl)-Methyl-Amine((2E)-4-((3-(4-bromophenyl)-1-benzofuran-6-yl)oxy)but-2-en-1-yl)(methyl)(prop-2-en-1-yl)amine[(2E)-4-{[3-(4-bromophenyl)-1-benzofuran–6–yl]oxy}but–2–en–1–yl](methyl)(prop–2–en–1–yl)amine